Forum Update: Supporting Community-Led Discussion
The forum was created as a space for shared learning and peer support, and as the community grows, we want to lean more fully into that purpose.
Going forward, PAAB will be taking a more listening-first role in forum discussions. Rather than responding immediately to every question, we’ll be encouraging members to engage with one another, share experiences, and help build collective understanding. PAAB will continue to monitor conversations and will step in to:
- Correct any misunderstandings
- Provide guidance when questions remain unanswered after a few days
- Support discussions where official clarification is needed
Our goal is to foster a collaborative, trusted community where knowledge is shared and strengthened by everyone’s contributions.
Thank you for being part of the conversation.
-
Our non-Canadian client (let’s assume Germany) is exploring sponsored disease awareness content (i.e. about “disease state” and “company X’s commitment to that disease state) on LinkedIn. They want to target people based on their interests/professions on the platform, and if possible, geo-target to reach people (including physicians and patients) with the right interests in Canada. Given that this is disease state content, are there any restrictions we would need to be aware of? Given that the company resides outside of Canada, would this be exempt from PAAB review?
-
Our non-Canadian client (let’s assume Germany) is exploring sponsored disease awareness content (i.e. about “disease state” and “company X’s commitment to that disease state) on LinkedIn. They want to target people based on their interests/professions on the platform, and if possible, geo-target to reach people (including physicians and patients) with the right interests in Canada. Given that this is disease state content, are there any restrictions we would need to be aware of? Given that the company resides outside of Canada, would this be exempt from PAAB review?
Hey @tmcd
The PAAB code applies to Canadian companies or to companies targeting content to Canadian healthcare professionals and patients. Please see the Health Canada document “The Distinction Between Advertising and Other Activities” for further clarification on how the content and role of the sponsor may impact if a piece is considered advertising.
In the example provided in your question, a truly disease state only piece with no messaging about treatment and no direct or implied link to a product the sponsor has a vested interest in, may be exempt from PAAB review. There are variables that could render the piece subject to review (e.g. focusing on a disease mechanism of action for which only exogenous compounds target or are being developed to target; inclusion of a link to a brand page or treatment-related information, etc.). Another note of caution is that this would likely be considered direct to consumer advertising and would be subject to consumer regulations as well.
